Landscape of phase 1 clinical trials for minors with cancer in the United States
- 4 September 2020
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (11) , e28694
Abstract
Objectives: Understanding trends in characteristics of early phase trials that allow minors with cancer to participate may inform additional efforts to improve cancer drug development for young people.Methods: We accessed data for oncology phase 1 or phase 1/2 trials in the United States from ClinicalTrials.gov with lower age bound for eligibility P ≤ .02). No other temporal trends were seen. The median times from first‐in‐adult to first‐in‐pediatric for monotherapy and combination trials were 5.7 and 3.3 years, respectively.Conclusion: The paucity of clear temporal trends highlights the need for innovation in early drug development for young people. Our analysis serves as a benchmark against which to evaluate initiatives to improve pediatric cancer drug development.Keywords
This publication has 20 references indexed in Scilit:
- Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational AgentsClinical Cancer Research, 2017
- Innovations for phase I dose-finding designs in pediatric oncology clinical trialsContemporary Clinical Trials, 2016
- Modernizing Eligibility Criteria for Molecularly Driven TrialsJournal of Clinical Oncology, 2015
- Aging and Risk of Severe, Disabling, Life-Threatening, and Fatal Events in the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2014
- A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trialsEuropean Journal of Cancer, 2013
- The superiority of the time-to-event continual reassessment method to the rolling six design in pediatric oncology Phase I trialsClinical Trials, 2011
- A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trialsContemporary Clinical Trials, 2010
- Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six DesignJournal of Clinical Oncology, 2008
- Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct EfficiencyJournal of Clinical Oncology, 2005
- Conduct of phase I trials in children with cancer.Journal of Clinical Oncology, 1998